Green Tea Extract Increases Soluble RAGE and Improves Renal Function in Patients with Diabetic Nephropathy

다국어 초록 (Multilingual Abstract)

One of the proposed mechanisms for the development of diabetic nephropathy (DN) is the increase of end products of advanced glycosylation (AGEs), which bind to its receptor (RAGE), favoring nephron cellular damage. An isoform of this receptor is soluble RAGE (sRAGE), which can antagonize AGE-altered intracellular signaling. It has known that green tea extract (GTE) increases the expression of sRAGE, but it is unknown whether this could improve kidney function. The objective of this study was to evaluate the effect of the administration of GTE on the concentrations of sRAGE, renal function, and metabolic profile in patients with type 2 diabetes mellitus (T2DM) and DN. A randomized, double-blinded, placebo-controlled clinical trial was carried out in 39 patients who received GTE (400 mg every 12 h) or placebo for 3 months. sRAGE levels, renal function, and metabolic parameters were determined before and after the intervention. In the GTE group, there were statistically significant increase on sRAGE (320.55 ± 157.63 pg/mL vs. 357.59 ± 144.99 pg/mL; P = .04) and glomerular filtration rate (GFR; 66.44 ± 15.17 mL/min/1.73 m2 vs. 71.70 ± 19.33 mL/min/1.73 m2; P = .04), and a statistically significant decrease in fasting serum glucose (7.62 ± 3.00 mmol/L vs. 5.86 ± 1.36 mmol/L; P ≤ .01) and triacylglycerols (1.91 ± 0.76 mmol/L vs. 1.58 ± 0.69; P = .02). Administration of GTE increases the serum concentration of sRAGE and the GFR and decreases the concentration of fasting serum glucose and triacylglycerols. The study was registered in ClinicalTrials.gov with the identifier NCT03622762.

참고문헌 (Reference)

1 Shumer DE, "乳鼠心肌提取" 176 : 139-148, 2017

2 Hu J, "The safety of green tea and green tea extract consumption in adults—Results of a systematic review" 95 : 412-433, 2018

3 Dinh TC, "The effects of green tea on lipid metabolism and its potential applications for obesity and related metabolic disorders—An existing update" 13 : 1667-1673, 2019

4 Rai U, "Tetramethylpyrazine prevents diabetes by activating PI3K/Akt/GLUT-4 signalling in animal model of type-2 diabetes" 236 : 116836-, 2019

5 Adamopoulos C, "Systemic effects of AGEs in ER stress induction in vivo" 33 : 537-544, 2016

6 Maillard-Lefebvre H, "Soluble receptor for advanced glycation end products : A new biomarker in diagnosis and prognosis of chronic inflammatory diseases" 48 : 1190-1196, 2009

7 Ingels C, "Soluble RAGE and the RAGE ligands HMGB1 and S100A12in critical illness : Impact of glycemic control with insulin and relation with clinical outcome" 43 : 109-116, 2015

8 Fukami K, "Receptor for advanced glycation endproducts and progressive kidney disease" 24 : 54-60, 2015

9 Zhang L, "Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases" 283 : 35507-35516, 2008

10 Yang PY, "Protective effects of gliclazide on high glucose and AGEs-induced damage of glomerular mesangial cells and renal tubular epithelial cells via inhibiting RAGEp22phox-NF-kB pathway" 23 : 9099-9107, 2019

11 Nishikawa T, "Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage" 404 : 787-790, 2000

12 Jeyaseelan L, "Methods of determining sample sizes in clinical trials" 26 : 115-121, 1989

13 Wu LY, "Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model" 43 : 116-124, 2004

14 Yi W, "Green tea polyphenols ameliorate the early renal damage induced by a high-fat diet via ketogenesis/SIRT3 pathway" 2017 : 9032792-, 2017

15 Musso CG, "Glomerular filtration rate equations : A comprehensive review" 48 : 1105-1110, 2016

16 Masoume Akhbari, "Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy" Clinical Laboratory Publications 65 (65): 2019

17 "Erratum: Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Update Work Group. KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). (Kidney Int Suppl. 2017;7:1–59)" 7 : e1-, 2017

18 Waltner-Law ME, "Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production" 277 : 34933-34940, 2002

19 Liu CY, "Effects of green tea extract on insulin resistance and glucagonlike peptide 1 in patients with type 2 diabetes and lipid abnormalities : A randomized, double-blinded, and placebo-controlled trial" 9 : 1-9, 2014

20 Toolsee NA, "Effectiveness of green tea in a randomized human cohort : Relevance to diabetes and its complications" 2013 : 412379-, 2013

21 Yu Z, "Effect of green tea supplements on liver enzyme elevation : Results from a randomized intervention study in the United States" 10 : 571-579, 2017

22 Liu K, "Effect of green tea on glucose control and insulin sensitivity : A metaanalysis of 17 randomized controlled trials" 98 : 340-348, 2013

23 Quezada-Ferna´ndez P, "Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus : A randomised, double-blind, placebo-controlled trial" 70 : 977-985, 2019

24 Huang SM, "EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes" 57 : 2264-2268, 2013

25 Darlington O, "Costs and healthcare resource use associated with risk of cardiovascular morbidity in patients with chronic kidney disease : Evidence from a systematic literature review" 38 : 994-1010, 2021

26 Wang KJ, "Corn silk(Zea mays L. ), a source of natural antioxidants with a-amylase, a-glucosidase, advanced glycation and diabetic nephropathy inhibitory activities" 110 : 510-517, 2019

27 American Diabetes Association, "Classification and diagnosis of diabetes : Standards of medical care in diabetes 2019" 42 : S13-S28, 2019

28 Sugiura C, "Catechins and caffeine inhibit fat accumulation in mice through the improvement of hepatic lipid metabolism" 2012 : 520510-, 2012

29 Kuo C, "Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers" 7 : 351-354, 1998

30 Chacko SM, "Beneficial effects of green tea : A literature review" 5 : 1-9, 2010

31 Kuhad A, "Attenuation of diabetic nephropathy by tocotrienol : Involvement of NFkB signaling pathway" 84 : 296-301, 2009

32 Ingrasciotta Y, ": Direct healthcare costs of chronic kidney disease management in Italy : What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents" 30 : 65-77, 2021